Hereditary Cancer Syndromes

Your Genes Speak, We Translate.


brca gene mutation
brca gene mutations

HerediGENE® is an assay that fully analyzes a panel of 52 genes, including BRCA Gene mutations.

These 52 genes are associated with increased risk of developing breast, ovarian, colon and other hereditary cancer syndromes.

The test identifies those family members at risk of developing cancer who can benefit from risk reduction management.

It detects gene mutations (including the brca gene mutations – BRCA1BRCA2 Genes) that may pass increased cancer risk to your children.

It identifies the family members that do not carry the pathogenic mutation  that was detected in the family, relieving them of the stress of developing hereditary cancer syndromes or foregoing unnecessary interventions.

brca gene mutation

International Guidelines for Multi-Gene Testing

The latest international guidelines (ASCO, ESMO, NCCN and American Society of Breast Surgeons) strongly recommend, instead of BRCA1/2 only, the use of multi-gene panels for a better coverage of the gene variants associated with an increased risk of breast, prostate, colon, pancreatic, ovarian cancer etc.